22 May 2025
Simplify PCI! Know where and how to win with drug-coated balloon
Sponsored by B. Braun
Anchorperson:
R. Jeger
Spokesperson:
S. Eccleshall
Summary
This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into how DCBs can be used to manage complex cases such as multivessel disease, bifurcation lesions, and improve outcomes in diabetic patients.
Learning Objectives
- To learn more about the safety and effectiveness of the best-investigated coronary drug-coated balloons
- To learn about the strengths of drug-coated balloons in different indications, including de-novo, multivessel disease, bifurcations, CTO and diabetic patients
- To gain an understanding on how drug-coated balloon can reduce complexity in today’s PCI
- To gain confidence in using drug-coated balloon with a data-driven treatment choice
- To get an understanding how to use the hybrid approach especially for challenging lesions to improve clinical outcome
- To get the latest clinical data on the best-investigated coronary sirolimus drug-coated balloon in a real-world setting